key: cord-0817495-qa4nhyfq
authors: Kirschen, Matthew P.; McGowan, Nancy; Topjian, Alexis
title: Brain Death Evaluation in Children With Suspected or Confirmed Coronavirus Disease 2019
date: 2020-12-03
journal: Pediatr Crit Care Med
DOI: 10.1097/pcc.0000000000002650
sha: b6a555b74237d965b0e31bbdd017cfd11603ba5b
doc_id: 817495
cord_uid: qa4nhyfq

OBJECTIVES: To discuss the challenges of conducting a death by neurologic criteria or brain death evaluation in the coronavirus disease 2019 era and provide guidance to mitigate viral transmission risk and maintain patient safety during testing. DESIGN: Not applicable. SETTING: Not applicable. PATIENTS: Children with suspected or confirmed coronavirus disease 2019 who suffer catastrophic brain injury due to one of numerous neurologic complications or from an unrelated process and require evaluation for death by neurologic criteria. INTERVENTIONS: Not applicable. MEASUREMENTS AND MAIN RESULTS: There is a risk to healthcare providers from aerosol generation during the neurologic examination and apnea test for determination of death by neurologic criteria. In this technical note, we provide guidance to mitigate transmission risk and maintain patient safety during each step of the death by neurologic criteria evaluation. Clinicians should put on appropriate personal protective equipment before performing the death by neurologic criteria evaluation. Risk of aerosol generation and viral transmission during the apnea test can be mitigated by using continuous positive airway pressure delivered via the ventilator as a means of apneic oxygenation. Physicians should assess the risk of transporting coronavirus disease 2019 patients to the nuclear medicine suite to perform a radionucleotide cerebral blood flow study, as disconnections to and from the ventilator for transport and inadvertent ventilator disconnections during transport can increase transmission risk. CONCLUSIONS: When conducting the neurologic examination and apnea test required for death by neurologic criteria determination in patients with suspected or confirmed coronavirus disease 2019, appropriate modifications are needed to mitigate the risk of viral transmission and ensure patient safety.

of brain death (or death by neurologic criteria [DNC] ) in infants and children published by the American Academy of Pediatrics, the Society of Critical Care Medicine, and the Child Neurology Society do not address the risks of disease transmission (4) . However, recent guidance has been published in adults (5) . In this technical note, we highlight considerations to minimize the risk of SARS-CoV-2 transmission to healthcare providers while evaluating children for DNC.

In children, the risk of death from COVID-19 is low (6-9), but it is possible that they may suffer catastrophic illness while coinfected with SARS-CoV-2 or have a complication of COVID-19 that could lead to catastrophic, irreversible brain injury and death. In this context, clinicians should carefully consider the components of the DNC evaluation that carry added risk of SARS-CoV-2 transmission. For example, the performance of the apnea test is an aerosol-generating procedure when patients are disconnected from mechanical ventilation. Eliciting a gag or cough reflex has the potential to release viral particles into the air. Disconnecting the patient from the ventilator for transport to the nuclear medicine suite to perform a radionucleotide cerebral blood flow study can increase the risk of virus exposure for hospital staff, patients, and families. Finally, communication with the family often requires multiple people to be in close proximity, thereby increasing transmission risk.

In this technical note, we provide guidance for performing each step of the DNC evaluation in infants and children with suspected or confirmed COVID-19. Institutions should consider updating their policies and procedures accordingly.

If an evaluation for DNC is anticipated and the patient's COVID-19 status is unknown, providers should arrange COVID-19 testing before initiating the evaluation. The assessment of prerequisites is no different from that in patients without COVID-19.

Before clinicians perform the DNC neurologic examination, they should put on appropriate personal protective equipment, because the examination could be aerosol-generating. The DNC neurologic examination is no different from that in patients without COVID-19.

The two components of the examination that may pose additional risk to the examiner are assessing the cough and gag reflexes. The gag reflex is assessed by stimulation of the posterior pharyngeal wall bilaterally. The cough reflex is evaluated by deep tracheal suctioning, typically through the endotracheal tube (ETT). For patients with COVID-19, use inline suction without disconnecting the ventilator and ensure the ETT cuff is inflated to minimize the risk of aerosolization. Either of these reflexes, when intact, can stimulate a cough that is aerosol generating; however, it is unknown whether aerosolization also occurs from the posterior or nasopharynx when the patient is connected to a closed ventilator circuit.

The apnea test carries the greatest risk of SARS-CoV-2 transmission to healthcare providers and family members. Protocols for performing the apnea test in children have been published, and the fundamental principles are the same in patients with COVID-19 (4, 10) .

To avoid hypoxemia during the apnea test, apneic oxygenation is usually provided using Fio 2 1.0 via tracheal insufflation or T-piece (11) . In pediatrics, it is common and often preferred to use continuous positive airway pressure (CPAP) via a flow inflating resuscitation bag (e.g., Mapleson circuit), which can provide an Fio 2 of 1.0 and maintain a positive end-expiratory pressure to prevent atelectasis and a reduction in functional residual capacity (10, 12) . Each of these methods requires disconnection of the patient from the ventilator and risk spreading aerosolized virus. Conducting the apnea test using CPAP delivered via the ventilator is a reasonable alternative to reduce the risk of viral transmission ( Table 1) .

Additional risk to healthcare providers during the apnea test can occur if the patient requires hand-ventilation using a resuscitation bag via the ETT for severe hypoxemia or hemodynamic instability. These risks can be mitigated by using more selective criteria for which patients undergo the apnea test; one recent study reported less than 1% failure in performing the apnea test when patients were first determined by a pediatric intensivist to be physiologically stable for testing (10) . Patients in whom the apnea test was deferred had a higher oxygenation index and ventilator requirements compared with patients who had the apnea test performed. If the patient is deemed to be at high risk for decompensation during the apnea test such that it is deferred, an ancillary test is needed (see below).

Transcutaneous carbon dioxide (CO 2 ) monitoring (tcP CO2 ) can be used to follow the rise in partial pressure of CO 2 and guide the timing of arterial blood gas sampling to minimize the apnea duration and potential risk of cardiopulmonary instability (13) . Additionally, a modified apnea test has been proposed for patients at high risk of severe hypoxemia or hemodynamic instability, in which minute ventilation is reduced by at least 50% and serial blood gas measurements are made until the arterial partial pressure of CO 2 reaches the appropriate threshold. At that time, the ventilator is changed to the CPAP mode and the patient is observed for 60 seconds. If no spontaneous respirations are observed, the patient meets criteria for DNC (14) .

Finally, if it is necessary to disconnect the patient from the ventilator for manual ventilation, providers could consider briefly clamping the ETT during the transition from the ventilator to a resuscitation bag in order to reduce the risk for aerosol transmission. Personal protective equipment should minimize the risk to the provider. • If a resuscitation bag is required, consider briefly clamping the endotracheal tube for the transition from the ventilator to the resuscitation bag to maintain functional residual capacity and limit the risk of viral transmission

• The DNC evaluation may be repeated after sufficient time to allow for improvement of cardiopulmonary status, or an ancillary study may be pursued DNC = death by neurologic criteria.

Coronavirus Disease (COVID-19) Pandemic. Available at

PeDI-Collaborative: Pediatric airway management in COVID-19 patients: Consensus guidelines from the Society for Pediatric Anesthesia's Pediatric Difficult Intubation Collaborative and the Canadian Pediatric Anesthesia Society

Interim guidance for basic and advanced life support in children and neonates with suspected or confirmed COVID-19

Clinical reportguidelines for the determination of brain death in infants and children: An update of the 1987 task force recommendations

Brain death evaluation during the pandemic

ptbnet COVID-19 Study Group: COVID-19 in children and adolescents in Europe: A multinational, multicentre cohort study

COVID-NET Surveillance Team: Hospitalization rates and characteristics of children aged <18 years hospitalized with laboratory-confirmed COVID-19 -COVID-NET, 14 States

Centers for Disease Control and Prevention: CDC COVID Data Tracker: Maps, Charts, and Data Provided by the CDC. Available at

COVID-19 Data: North America Pediatric ICUs

Apnea testing using continuous positive airway pressure when determining death by neurologic criteria in children: Retrospective analysis of potential adverse events

Apnea testing for the determination of brain death: A systematic scoping review

Efficacy of a T-piece system and a continuous positive airway pressure system for www

apnea testing in the diagnosis of brain death

Transcutaneous carbon dioxide monitoring during apnea testing for determination of neurologic death in children: A retrospective case series

The modified apnea test during brain death determination: An alternative in patients with hypoxia

Organ support after death by neurologic criteria in pediatric patients

The authors have disclosed that they do not have any potential conflicts of interest.For information regarding this article, E-mail: kirschenm@chop. edu